Open beta · everything is free with an account while we build. Founding accounts get preferred pricing when paid plans arrive. Create yours →
JH

JAMES HALL

B HALL STRATEGIES, LLC · Washington, DC
Registered · LDAActive

At a glance

Works on
Professional highlights appear here once this profile is claimed. Claim it →

Background

Career
Washington, DC · current
Government experience
Staff Director
Senate Veterans Affairs Committee; Legislative Director, Senator Bob Graham
Covered official positions, as disclosed on federal filings

The past 12 months

Clients
18
past 12 months
Filings
18
past 12 months
Agencies contacted
SENATE

Specific issues

Monitor issues related to artificial intelligence.
Medicare/Medicaid · 2026 Q1
Issues related to drug pricing.
Pharmacy · 2026 Q1
Issues related to drug pricing. Issues related to PBM reform.
Pharmacy · 2026 Q1
Issues related to H.R.842 - Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act.
Medicare/Medicaid · 2026 Q1
Issues related to Medicare reimbursement.
Medicare/Medicaid · 2026 Q1
Issues related to domestic pharmaceutical production.
Pharmacy · 2026 Q1

Clients

$██,███ / qtrFree in beta
$██,███ / qtrFree in beta
$██,███ / qtrFree in beta
$██,███ / qtrFree in beta

Sources

This profile is built from the public record: filings in the U.S. Senate Lobbying Disclosure Act system. lda.senate.gov ↗

Recent filings14
2026 Q1
TIBER CREEK HEALTH STRATEGIES, INC. ON BEHALF OF AMGEN, INC.
Q1lda.gov →
2026 Q1
TIBER CREEK GROUP ON BEHALF OF TAKEDA PHARMACEUTICALS AMERICA, INC.
Q1lda.gov →
2026 Q1
TIBER CREEK HEALTH STRATEGIES, INC. ON BEHALF OF ELI LILLY AND COMPANY
Q1lda.gov →
2026 Q1
TIBER CREEK GROUP ON BEHALF OF MERCK & CO., INC.
Q1lda.gov →
2026 Q1
TIBER CREEK GROUP ON BEHALF OF ORGANON, LLC
Q1lda.gov →
2026 Q1
TIBER CREEK GROUP ON BEHALF OF PHLOW CORPORATION
Q1lda.gov →
2026 Q1
TIBER CREEK HEALTH STRATEGIES, INC. OBO FRESENIUS MEDICAL CARE NORTH AMERICA
Q1lda.gov →
2026 Q1
TIBER CREEK GROUP ON BEHALF OF BEONE MEDICINES USA, INC.
Q1lda.gov →
2026 Q1
TIBER CREEK GROUP ON BEHALF OF DAIICHI SANKYO, INC.
Q1lda.gov →
2026 Q1
TIBER CREEK GROUP ON BEHALF OF GILEAD SCIENCES, INC.
Q1lda.gov →
2026 Q1
TIBER CREEK GROUP ON BEHALF OF ASTELLAS PHARMA US, INC.
Q1lda.gov →
2026 Q1
TIBER CREEK GROUP ON BEHALF OF MYRIAD GENETICS, INC.
Q1lda.gov →
2026 Q1
TIBER CREEK HEALTH STRATEGIES, INC. ON BEHALF OF NOVARTIS
Q1lda.gov →
2026 Q1
TIBER CREEK GROUP ON BEHALF OF JAZZ PHARMACEUTICALS
Q1lda.gov →